J. C. Yao, M. Hassan, and A. Phan, One Hundred Years after 'Carcinoid': Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, vol.26, issue.18, pp.3063-72, 2008.

A. Dasari, C. Shen, and D. Halperin, Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States, JAMA Oncology, vol.3, issue.10, pp.1335-1377, 2017.

T. De-baere, Y. Arai, and R. Lencioni, Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion, Cardiovascular and Interventional Radiology, vol.39, issue.3, pp.334-377, 2016.

R. S. Chamberlain, D. Canes, and K. T. Brown, Hepatic Neuroendocrine Metastases: Does Intervention Alter Outcomes?, Journal of the American College of Surgeons, vol.190, issue.4, pp.432-477, 2000.

G. P. Mcentee, D. M. Nagorney, and L. K. Kvols, Cytoreductive Hepatic Surgery for Neuroendocrine Tumors, Surgery, vol.108, issue.6, pp.1091-96, 1990.

M. Pavel, E. Baudin, and A. Couvelard, ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary, and Barcelona Consensus Conference participants, vol.95, pp.157-76, 2012.

A. Frilling, I. M. Modlin, and M. Kidd, Recommendations for Management of Patients with Neuroendocrine Liver Metastases, The Lancet. Oncology, vol.15, issue.1, pp.8-21, 2014.

A. Kennedy, L. Bester, and R. Salem, Role of Hepatic Intra-Arterial Therapies in Metastatic Neuroendocrine Tumours (NET): Guidelines from the NET-Liver-Metastases Consensus Conference, vol.17, pp.29-37, 2015.

M. Pavel, D. O'toole, and C. F. , ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site, Neuroendocrinology, vol.103, issue.2, pp.172-85, 2016.

A. Roche, B. V. Girish, and T. De-baere, Prognostic Factors for Chemoembolization in Liver Metastasis from Endocrine Tumors, Hepato-Gastroenterology, vol.51, issue.60, pp.1751-56, 2004.

J. C. Yao, M. H. Shah, and T. Ito, Everolimus for Advanced Pancreatic Neuroendocrine Tumors, New England Journal of Medicine, vol.364, issue.6, pp.514-537, 2011.

R. C. Gaba, M. O. Baerlocher, and B. Nikolic, Clinical and Imaging Follow-up Practices after Transarterial Therapy for Primary and Secondary Hepatic Malignancies: Results of an Online Survey, Academic Radiology, vol.22, issue.12, pp.1510-1525, 2015.

I. M. Modlin, K. Oberg, and D. C. Chung, Gastroenteropancreatic Neuroendocrine Tumours, The Lancet. Oncology, vol.9, issue.1, pp.61-72, 2008.

S. Sahu, R. Schernthaner, and R. Ardon, Imaging Biomarkers of Tumor Response in Neuroendocrine Liver Metastases Treated with Transarterial Chemoembolization: Can Enhancing Tumor Burden of the Whole Liver Help Predict Patient Survival?, Radiology, vol.283, issue.3, pp.883-94, 2017.

T. De-baere, Y. Arai, and R. Lencioni, Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion, Cardiovascular and Interventional Radiology, vol.39, issue.3, pp.334-377, 2016.

J. Bruix, M. Sherman, and P. Committee, Management of Hepatocellular Carcinoma, Hepatology, vol.42, issue.5, pp.1208-1244, 2005.

R. Lencioni and J. M. Llovet, Modified RECIST (MRECIST) Assessment for Hepatocellular Carcinoma, Seminars in Liver Disease, vol.30, issue.1, pp.52-60, 2010.

, US Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE), Version 4.0. NIH publication 09-7473, vol.29, 2009.

K. Günter, A. Perren, and P. U. Heitz, The Gastroenteropancreatic Neuroendocrine Cell System and Its Tumors: The WHO Classification, Annals of the New York Academy of Sciences, vol.1014, issue.1, pp.13-27, 2004.

S. Hur, J. W. Chung, and H. C. Kim, Survival Outcomes and Prognostic Factors of Transcatheter Arterial Chemoembolization for Hepatic Neuroendocrine Metastases, Journal of Vascular and Interventional Radiology: JVIR, vol.24, issue.7, pp.947-56, 2013.

F. Marrache, M. P. Vullierme, and C. Roy, Arterial Phase Enhancement and Body Mass Index Are Predictors of Response to Chemoembolisation for Liver Metastases of Endocrine Tumours, British Journal of Cancer, vol.96, issue.1, pp.49-55, 2007.

S. C. Pitt, J. Knuth, and J. M. Keily, Hepatic Neuroendocrine Metastases: Chemo-or Bland Embolization?, Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract, vol.12, issue.11, pp.1951-60, 2008.

T. De-baere, F. Deschamps, and L. Tselikas, GEP-NETS Update: Interventional Radiology: Role in the Treatment of Liver Metastases from GEP-NETs, European Journal of Endocrinology, vol.172, issue.4, pp.151-166, 2015.

X. D. Dong and C. Bi, Hepatic Artery Chemoembolization for the Treatment of Liver Metastases from Neuroendocrine Tumors: A Long-Term Follow-up in 123 Patients, Medical Oncology, vol.28, issue.1, pp.286-290, 2011.

S. Grozinsky-glasberg, G. Kaltsas, and M. Kaltsatou, Hepatic Intra-Arterial Therapies in Metastatic Neuroendocrine Tumors: Lessons from Clinical Practice, Endocrine, vol.60, issue.3, pp.499-509, 2018.

V. G. Halappa, C. P. Corona-villalobos, and S. Bonekamp, Neuroendocrine Liver Metastasis Treated by Using Intraarterial Therapy: Volumetric Functional Imaging Biomarkers of Early Tumor Response and Survival, Radiology, vol.266, issue.2, pp.502-515, 2013.

B. Gulpinar, E. Peker, and M. Kul, Liver Metastases of Neuroendocrine Tumors: Is It Possible to Diagnose Different Histologic Subtypes Depending on Multiphasic CT Features?, Abdominal Radiology, vol.44, issue.6, pp.2147-55, 2019.

A. R. Padhani and M. O. Leach, Antivascular Cancer Treatments: Functional Assessments by Dynamic Contrast-Enhanced Magnetic Resonance Imaging, Abdominal Imaging, vol.30, issue.3, pp.324-365, 2005.

Z. Li, S. Bonekamp, and V. G. Halappa, Islet Cell Liver Metastases: Assessment of Volumetric Early Response with Functional MR Imaging after Transarterial Chemoembolization, Radiology, vol.264, issue.1, pp.97-109, 2012.

M. Dhir, R. Shrestha, and J. L. Steel, Initial Treatment of Unresectable Neuroendocrine Tumor Liver Metastases with Transarterial Chemoembolization Using Streptozotocin: A 20-Year Experience, Annals of Surgical Oncology, vol.24, issue.2, pp.450-59, 2017.

P. Ruszniewski, S. Ish-shalom, and M. Wymenga, Rapid and Sustained Relief from the Symptoms of Carcinoid Syndrome: Results from an Open 6-Month Study of the 28-Day Prolonged-Release Formulation of Lanreotide, Neuroendocrinology, vol.80, issue.4, pp.244-51, 2004.

C. T. Sofocleous, E. N. Petre, and M. Gonen, Factors Affecting Periprocedural Morbidity and Mortality and Long-Term Patient Survival after Arterial Embolization of Hepatic Neuroendocrine Metastases, Journal of Vascular and Interventional Radiology: JVIR, vol.25, issue.1, pp.22-30, 2014.

F. T. Bosman, World Health Organization Classification of Tumours 3. Lyon: International Agency for Research on Cancer, WHO Classification of Tumours of the Digestive System, 2010.

R. V. Lloyd, R. Y. Osamura, and G. Klöppel, World Health Organization Classification of Tumours, Lyon: International Agency for Research on Cancer, 2017.

S. Singla, C. M. Levea, and V. K. Pokuri, Ki67 Score as a Potential Predictor in the Selection of Liver-Directed Therapies for Metastatic Neuroendocrine Tumors: A Single Institutional Experience, Journal of Gastrointestinal Oncology, vol.7, issue.3, pp.441-489, 2016.

A. Ahmed, G. Turner, and B. King, Midgut Neuroendocrine Tumours with Liver Metastases: Results of the UKINETS Study, Endocrine-Related Cancer, vol.16, issue.3, pp.885-94, 2009.

A. T. Ruutiainen, M. C. Soulen, and C. M. Tuite, Chemoembolization and Bland Embolization of Neuroendocrine Tumor Metastases to the Liver, Journal of Vascular and Interventional Radiology: JVIR, vol.18, issue.7, pp.847-55, 2007.

B. K. Eriksson, E. G. Larsson, B. M. Skogseid, A. M. Löfberg, L. E. Lörelius et al., Liver Embolizations of Patients with Malignant Neuroendocrine Gastrointestinal Tumors, Cancer, vol.83, issue.11, pp.2293-2301, 1998.